List of Azevan Pharmaceuticals patents

List of Azevan Pharmaceuticals patents

List of Business Objects patents

List of The Euclid Chemical Company patents

List of Sommetrics, Inc. patents

List of funding rounds for CENTRI Technology

List of SBIR/STTR awards granted to Intelligent Hearing Systems Corp.

Patents where

Current Assignee

Name

is

‌

Azevan Pharmaceuticals

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 11319306 Compositions and methods for treating neurodegenerative diseases	Patent 11319306 was granted and assigned to Azevan Pharmaceuticals on May, 2022 by the United States Patent and Trademark Office.	‌ Azevan Pharmaceuticals	‌ Azevan Pharmaceuticals		United States Patent and Trademark Office	11319306	May 3, 2022
	‌ US Patent 7119083 β-Lactamyl vasopressin V	Patent 7119083 was granted and assigned to Azevan Pharmaceuticals on October, 2006 by the United States Patent and Trademark Office.		‌ Azevan Pharmaceuticals		United States Patent and Trademark Office	7119083	October 10, 2006
	‌ US Patent 7268125 β-lactamyl vasopressin V	Patent 7268125 was granted and assigned to Azevan Pharmaceuticals on September, 2007 by the United States Patent and Trademark Office.		‌ Azevan Pharmaceuticals		United States Patent and Trademark Office	7268125	September 11, 2007
	‌ US Patent 11628160 Compositions and methods for treating brain injury	Patent 11628160 was granted and assigned to Azevan Pharmaceuticals on April, 2023 by the United States Patent and Trademark Office.	‌ Azevan Pharmaceuticals	‌ Azevan Pharmaceuticals		United States Patent and Trademark Office	11628160	April 18, 2023
	‌ US Patent 10364236 Compositions and methods for treating neurodegenerative diseases	Patent 10364236 was granted and assigned to Azevan Pharmaceuticals on July, 2019 by the United States Patent and Trademark Office.	‌ Azevan Pharmaceuticals	‌ Azevan Pharmaceuticals		United States Patent and Trademark Office	10364236	July 30, 2019
	‌ US Patent 9597314 Beta-lactamylalkanoic acids for treating premenstrual disorders	Patent 9597314 was granted and assigned to Azevan Pharmaceuticals on March, 2017 by the United States Patent and Trademark Office.		‌ Azevan Pharmaceuticals		United States Patent and Trademark Office	9597314	March 21, 2017
	‌ US Patent 8426400 β-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists	Patent 8426400 was granted and assigned to Azevan Pharmaceuticals on April, 2013 by the United States Patent and Trademark Office.		‌ Azevan Pharmaceuticals		United States Patent and Trademark Office	8426400	April 23, 2013
	‌ US Patent 9987265 Methods for treating post traumatic stress disorder	Patent 9987265 was granted and assigned to Azevan Pharmaceuticals on June, 2018 by the United States Patent and Trademark Office.	‌ Azevan Pharmaceuticals	‌ Azevan Pharmaceuticals		United States Patent and Trademark Office	9987265	June 5, 2018
	‌ US Patent 10953001 Methods for treating post traumatic stress disorder	Patent 10953001 was granted and assigned to Azevan Pharmaceuticals on March, 2021 by the United States Patent and Trademark Office.	‌ Azevan Pharmaceuticals	‌ Azevan Pharmaceuticals		United States Patent and Trademark Office	10953001	March 23, 2021
	‌ US Patent 8048874 Beta-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists	Patent 8048874 was granted and assigned to Azevan Pharmaceuticals on November, 2011 by the United States Patent and Trademark Office.		‌ Azevan Pharmaceuticals		United States Patent and Trademark Office	8048874	November 1, 2011
	‌ US Patent 9802925 Compositions and methods for treating neurodegenerative diseases	Patent 9802925 was granted and assigned to Azevan Pharmaceuticals on October, 2017 by the United States Patent and Trademark Office.	‌ Azevan Pharmaceuticals	‌ Azevan Pharmaceuticals		United States Patent and Trademark Office	9802925	October 31, 2017
	‌ US Patent 9376424 Methods for treating post traumatic stress disorder	Patent 9376424 was granted and assigned to Azevan Pharmaceuticals on June, 2016 by the United States Patent and Trademark Office.		‌ Azevan Pharmaceuticals		United States Patent and Trademark Office	9376424	June 28, 2016

12 results

0 selected

12 results

0 selected